Total planned funding: $506,454,197
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $506,454,197 |
Organizational Types
NGO | $128,962,080 |
Private Contractor | $99,764,119 |
Own Agency | $82,904,353 |
Unknown | $66,833,412 |
Host Country Government Agency | $58,944,378 |
University | $45,369,964 |
Parastatal | $9,333,344 |
Implementing Agency | $5,119,377 |
FBO | $4,608,361 |
Other USG Agency | $2,721,051 |
Multi-lateral Agency | $1,893,758 |
Program Areas
Treatment | $149,607,511 |
Prevention | $103,280,867 |
Care | $100,352,419 |
Governance and Systems | $69,231,265 |
Management and Operations | $53,405,661 |
Testing | $30,576,474 |
Budget Codes
HTXS: Treatment: Adult Treatment | $128,509,863 |
HVMS: Management and Operations | $53,405,661 |
HKID: Care: Orphans and Vulnerable Children | $44,129,558 |
HVOP: Sexual Prevention: Other Sexual Prevention | $32,837,535 |
OHSS: Health Systems Strengthening | $31,387,329 |
HVCT: Testing: HIV Testing and Counseling | $30,576,474 |
HVSI: Strategic Information | $29,234,422 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $28,794,853 |
HBHC: Care: Adult Care and Support | $26,370,635 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,850,626 |
HVTB: Care: TB/HIV | $18,883,977 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,199,704 |
PDTX: Treatment: Pediatric Treatment | $14,082,498 |
PDCS: Care: Pediatric Care and Support | $10,968,249 |
HLAB: Laboratory Infrastructure | $8,609,514 |
HTXD: Treatment: ARV Drugs | $7,015,150 |
HMBL: Biomedical Prevention: Blood Safety | $3,194,118 |
HMIN: Biomedical Prevention: Injection Safety | $2,404,031 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$64,620,679
Countries/Regions
USG Aggregated Agencies:
$56,213,596
Countries/Regions
Not Available:
$50,966,177
Countries/Regions